Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27292104

Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2016 Aug 25
First author
Kantarjian HM

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2016 Nov 24;375(21):2100-2101. doi: 10.1056/NEJMc1612040.
    note
    Source null
    related pmid
    27959720
    relationship
    Comment in
  2. citation
    N Engl J Med. 2016 Nov 24;375(21):2100. doi: 10.1056/NEJMc1612040.
    note
    Source null
    related pmid
    27959721
    relationship
    Comment in
  3. citation
    Cancer Discov. 2017 Oct;7(10):1054-1055. doi: 10.1158/2159-8290.CD-NB2017-120.
    note
    Source null
    related pmid
    28851687
    relationship
    Comment in

Authors and identifiers

  1. name
    Kantarjian HM
    type
    Author
  2. name
    DeAngelo DJ
    type
    Author
  3. name
    Stelljes M
    type
    Author
  4. name
    Martinelli G
    type
    Author
  5. name
    Liedtke M
    type
    Author
  6. name
    Stock W
    type
    Author
  7. name
    Gökbuget N
    type
    Author
  8. name
    O'Brien S
    type
    Author
  9. name
    Wang K
    type
    Author
  10. name
    Wang T
    type
    Author
  11. name
    Paccagnella ML
    type
    Author
  12. name
    Sleight B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kantarjian HM
    type
    Author
  2. name
    DeAngelo DJ
    type
    Author
  3. name
    Stelljes M
    type
    Author
  4. name
    Martinelli G
    type
    Author
  5. name
    Liedtke M
    type
    Author
  6. name
    Stock W
    type
    Author
  7. name
    Gökbuget N
    type
    Author
  8. name
    O'Brien S
    type
    Author
  9. name
    Wang K
    type
    Author
  10. name
    Wang T
    type
    Author
  11. name
    Paccagnella ML
    type
    Author
  12. name
    Sleight B
    type
    Author
bibliography ids
  1. nci-bib-febb7a1deb873a200843afd2
book metadata
content sha256
aaaa6f6c7a67215687d444921ce3aee8949133df2a3bbc77b6f7bba28b6dd0a4
document type
citation
dois
  1. 10.1056/NEJMoa1509277
electronic publication date
display
2016 Jun 12
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27292104
immutable id
pubmed:27292104@aaaa6f6c7a67215687d444921ce3aee8949133df2a3bbc77b6f7bba28b6dd0a4
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
8
name
The New England journal of medicine
nlm unique id
0255562
pages
740-53
volume
375
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2016 Nov 24;375(21):2100-2101. doi: 10.1056/NEJMc1612040.
    note
    Source null
    related pmid
    27959720
    relationship
    Comment in
  2. citation
    N Engl J Med. 2016 Nov 24;375(21):2100. doi: 10.1056/NEJMc1612040.
    note
    Source null
    related pmid
    27959721
    relationship
    Comment in
  3. citation
    Cancer Discov. 2017 Oct;7(10):1054-1055. doi: 10.1158/2159-8290.CD-NB2017-120.
    note
    Source null
    related pmid
    28851687
    relationship
    Comment in
outcomes validated
false
pmid
27292104
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
91cc474824af5ec0f04112a0b790ce78bb50a46a8a87e68d73408e665693c3c8
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Aug 25
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27292104/
title
Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.

Preserved source evidence · Not medical advice